(using CLSI and/or EUCAST breakpoints) (11) , with MICs of 4, Յ0.5, and 1 g/ml, respectively.
All 45 carbapenem-nonsusceptible P. aeruginosa strains were typed by pulsed-field gel electrophoresis (PFGE) (12) as described elsewhere. Thirty-four PFGE profiles were observed among the isolates, and clusters of six (one cluster), three (one cluster), and two (four clusters) strains were detected within the hospitals. The IMP-33-producing P. aeruginosa strains displayed a unique profile compared to the other strains evaluated. Multilocus sequence typing (MLST) of the IMP-33-producing strain was performed according to the instructions at the website http://pubmlst.org /paeruginosa/, and this strain was found to belong to ST466, which, according to the MLST database, has been previously observed in Australia and Spain.
Evaluation of the bla IMP-33 genetic environment by primer walking sequence analysis showed that this gene was carried in the first position of a class 1 integron structure displaying standard 5= and 3= conserved regions. This M␤L gene was followed by copies of aac(6=)-1b, bla OXA-2 , and aadA1. DNA digestion with S1 nuclease (13) and I-CeuI (14) was resolved by electrophoresis followed by Southern blotting, and hybridization with a bla IMP -specific probe was performed to determine the genetic location of bla . A single hybridization signal was obtained from the ICeuI preparation, demonstrating that this gene was chromosomally located. This result was confirmed by the absence of hybridization in the S1 nuclease preparations.
The bla IMP-33 and bla IMP-13 genes were cloned into the pPCRScriptCam SKϩ plasmid vector (Stratagene Cloning Systems, La Jolla, CA) and transformed in E. coli XL10 Blue, and transformants were selected in 30 g/ml of chloramphenicol. Plasmid constructs were sequenced, and recombinant strains were susceptibility tested as described above. The susceptibility profile of the recombinant strain carrying bla IMP-33 was almost identical to that of the strain with bla IMP-13 cloned into the same background, both displaying high MICs of penicillins alone or combined with currently available serine-␤-lactamase inhibitor combinations and cephalosporins. Carbapenem MICs were modestly elevated (range, 0.5 to 2 g/ml), and the aztreonam MIC was the same as that for the host strain carrying the cloning vector without insert (Յ0.12 g/ml; Table 1 ).
Quantitative reverse transcription-PCR was used to evaluate the expression of intrinsic carbapenem resistance mechanisms, including the efflux pumps MexAB-OprM, MexCD-OprJ, MexEF-OprN, and MexXY-OprM and chromosomal ampC. Assays were performed with high-quality, DNA-free RNA preparations as previously described (15) , by using custom primers (sequences and conditions available upon request). Relative expression was determined as 2 Ϫ⌬⌬T , where ⌬⌬T is the difference between the target gene and rpsL cycle threshold values, with custom-designed primers. Additionally, an OprD Western blot assay was performed as previously described (16) . The expression of the efflux pumpencoding genes and ampC and phenotypic expression of OprD in IMP-33-producing P. aeruginosa were not significantly different from those of the P. aeruginosa PAO1 control (Table 1) .
IMP-33 displayed high homology with IMP-13, which has been widely described in Italy during the last decade (1, 2, 4) .
Results from the SENTRY Program demonstrated that over the years, IMP-13 has been observed in hospitals in Rome and Genoa but not in Catania (2), and these results are similar to the literature reports that have not surveyed or detected elevated numbers of M␤L-producing strains in Sicily. This suggests that IMP-33 is not derived from IMP-13 and both enzymes could have an ancestor in common but evolved separately.
The increase in carbapenemase-producing strains in Europe and the endemic spread of these organisms in the southern countries of Europe that include Italy (4) are matters of significant concern and should be the focus of a broader regional effort to prevent the further dissemination of these isolates within and between countries.
Nucleotide sequence accession number. The nucleotide sequence of bla IMP-33 and the integron carrying this gene has been submitted to GenBank and assigned accession number JN848782. a Results were normalized by using rpsL and compared to P. aeruginosa PAO1, except for mexE, which was normalized by using strain PAM1020 (kindly supplied by Olga Lomovskaya). b NT, not tested.
